sodium N-(2-hydroxyethyl)-N-[2-[(1-oxotetradecyl)amino]ethyl]glycinate
sodium N-(2-hydroxyethyl)-N-[2-[(1-oxotetradecyl)amino]ethyl]glycinate(63556-21-8)
- Name: sodium N-(2-hydroxyethyl)-N-[2-[(1-oxotetradecyl)amino]ethyl]glycinate
- Synonyms:EINECS 264-311-5;Sodium N-(2-hydroxyethyl)-N-(2-((1-oxotetradecyl)amino)ethyl)glycinate;Glycine, N-(2-hydroxyethyl)-N-(2-((1-oxotetradecyl)amino)ethyl)-, monosodium salt;Glycine, N-(2-hydroxyethyl)-N-(2-((1-oxotetradecyl)amino)ethyl)-, sodium salt (1:1);
- Molecular Formula:C20H39N2NaO4
- Molecular Weight:394.52443
- CAS Registry Number:63556-21-8
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.63556-21-8 sodium N-(2-hydroxyethyl)-N-[2-[(1-oxotetradecyl)amino]ethyl]glycinate
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.63556-21-8 Glycine, N-(2-hydroxyethyl)-N-(2-((1-oxotetradecyl)amino)ethyl)-, monosodium salt
Assay:99% Transportation:By sea Application:Pharmaceutical industry
Min. Order:0
Supplier:Antimex Chemical Limied [
China (Mainland)] CAS No.63556-21-8 sodium N-(2-hydroxyethyl)-N-[2-[(1-oxotetradecyl)amino]ethyl]glycinate
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:sodium N-(2-hydroxyethyl)-N-[2-[(1-oxotetradecyl)amino]ethyl]glycinate
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.63556-21-8 Glycine, N-(2-hydroxyethyl)-N-(2-((1-oxotetradecyl)amino)ethyl)-, monosodium salt
Assay:99% Appearance:white powder Package:drum or based on customers' requirement Storage:normal temperature storage Transportation:by sea, by air Application:We have different specifications for different applications
Min. Order:1Metric Ton
Supplier:Bluecrystal chem-union [
China (Mainland)]
Other Product
- 142-78-9/LAURIC ACID MONOETHANOLAMIDE
- 16662-85-4/CARBOPHENOTHION SULFONE)
- 86588-86-5/[4,8':4',8'':4'',8''':4''',6''''-Quinque-2H-1- benzopyran]-3,3',3'',3''',3'''',5,5',5'',5''',5'''',7,7',- 7'',7''',7''''-pentadecol,2,2',2'',2''',2''''-pentakis- (3,4-dihydroxyphenyl)-3,3',3'',3''',3'''',4,4',4'',- 4''',4''''-decahydro-,(2R,2'R,2''R,2'''R,2''''R,- 3R,3'R,3''R,3'''R,3''''S,4R,4'R,4''R,4'''S)-
- 85618-15-1/MP 104
- 55830-66-5/Cyclopropanecarboxylic acid,3-(2,2-dichloroethenyl)-2,2-dimethyl-,(3-phenoxyphenyl)methyl ester,mixt. with 2-methyl-4-oxo-3-(2-propenyl)-2-cyclopenten- 1-yl 2,2-dimethyl-3-(2-methyl-1- propenyl)cyclopropanecarboxylate
- 16870-37-4/Amogastrin
- 133040-01-4/Eprosartan
- 34039-64-0/3-(3-butyl-3-methyltriazanylidene)-3H-pyrazole-4-carboxamide
- 52364-73-5/4'-(Octyloxy)-4-biphenylcarbonitrile
- 87896-35-3/ethyl 4-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-2-carboxylate
- 125187-56-6/emethallicin A
- 63783-94-8/baccharinoid B4
- 5286-10-2/cryogenine
- 5318-79-6/N,N-bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]benzene-1,4-dicarboxamide
- 84603-53-2/Butternut, ext.
- 96294-85-8/4-methyl-1-(propan-2-yl)-2-(propan-2-yloxy)benzene
- 929-75-9/3,6,9-trioxaundecamethylenediamine
- 97290-47-6/Acetic acid, ((2-acetamido-2-(2-((cyclohexylmethylamino)methyl)-4,6-dibromocarbaniloyl)ethyl)thio)-, (R)-
- 63556-21-8/sodium N-(2-hydroxyethyl)-N-[2-[(1-oxotetradecyl)amino]ethyl]glycinate
- 124989-36-2/6,10,14,18,22,26-Octacosahexaen-1-ol,3,7,11,15,19,23,27-heptamethyl- (9CI)
- 74039-24-0/4,6-Diamino-2-hydroxy-5-pyrimidinesulfonic acid
- 80546-17-4/TG 079
- 53806-80-7/Poly(oxy-1,2-ethanediyl), alpha-benzoyl-omega-hydroxy- (EO 3-10 mol and 15-45 mol)
- 759-94-4/Eradicane
- 34317-37-8/3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridine-4-carbaldehyde, compound with 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline (1:1)
- 4433-79-8/4'-Chloro-2',5'-dimethoxyacetoacetanilide
- 68511-87-5/Nonanedioic acid, reaction products with octanoic acid and tetraethylenepentamine
- 108089-34-5/5,12-Naphthacenedione,8-acetyl-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-10-[[octahydro-2-(2-hydroxypropyl)-4,10-dimethylpyrano[3,4-d]-1,3,6-dioxazocin-8-yl]oxy]-(9CI)
- 6340-87-0/Triclacetamol
- 151472-23-0/a1-EBP protein